hotspot -WSS

hotspot

author：comprehensive 2025-09-02 22:06:25 - browse：312

A woman uses her phone to scan a barcode. -- Health coverage from STAT — A Color Health service promises to make it easier to get cancer screenings. Color Health

Color Health wants to take away any reason you might have for skipping screenings for cancer.

The Silicon Valley company, which pivoted from cancer genomics to Covid-19 testing on a large and hugely profitable scale, has a new program that incorporates both its roots in cancer testing and its logistical experience from the pandemic. Called, simply, the Cancer Prevention and Screening Program, and built in partnership with the American Cancer Society, the program aims to make it easy to get the appropriate screenings, whether at a clinic or at home.

“If we can take away all your excuses for not doing the prevention, can we get you to do the prevention,” said Alicia Zhou, the company’s chief scientific officer. “It’s bringing the care to the patient, instead of bringing the patient to care.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： AI generated plenty of interest at JPM but not a lot of trust

Wikipedia

WSS

Change Healthcare can notify patients about the breach, HHS says

Parkinson’s finding may lead to tests and, someday, treatments

Letters to First Opinion on caregivers, digital health, and more

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

focus

hotspot

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA's Pazdur wants cancer trials to range beyond China alone

How one medical school became remarkably diverse

Think you might have Covid

Guidelines to prevent youth baseball injuries need more muscle

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Virginia high school admissions case could be legal follow

See how much Covid

Walensky prepares to leave CDC — and Congress — behind

My yearlong odyssey to get my son’s ADHD medication covered

explore

NIH director takes cautious approach to Biden drug pricing priority

Dewpoint Therapeutics lays off staff after losing partnerships

Shifting the focus from loneliness to social health

EU regulator recommends expanding Mounjaro approval to obesity

Ionis drug prevents swelling attacks due to hereditary angioedema

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

focus

entertainment

Wikipedia

explore